- Home
- HSIC vs CORT Comparison
HSIC vs CORT Comparison
Compare HSIC & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSIC
- CORT
- Stock Information
- Founded
- HSIC 1932
- CORT 1998
- Country
- HSIC United States
- CORT United States
- Employees
- HSIC N/A
- CORT N/A
- Industry
- HSIC Medical Specialities
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- HSIC Health Care
- CORT Health Care
- Exchange
- HSIC Nasdaq
- CORT Nasdaq
- Market Cap
- HSIC 8.4B
- CORT 7.6B
- IPO Year
- HSIC 1995
- CORT N/A
- Fundamental
- Price
- HSIC $67.05
- CORT $75.45
- Analyst Decision
- HSIC Buy
- CORT Strong Buy
- Analyst Count
- HSIC 12
- CORT 4
- Target Price
- HSIC $76.25
- CORT $139.00
- AVG Volume (30 Days)
- HSIC 1.4M
- CORT 675.5K
- Earning Date
- HSIC 11-04-2025
- CORT 10-29-2025
- Dividend Yield
- HSIC N/A
- CORT N/A
- EPS Growth
- HSIC 15.03
- CORT N/A
- EPS
- HSIC 3.11
- CORT 1.11
- Revenue
- HSIC $12,773,000,000.00
- CORT $716,080,000.00
- Revenue This Year
- HSIC $4.62
- CORT $30.62
- Revenue Next Year
- HSIC $3.55
- CORT $37.68
- P/E Ratio
- HSIC $21.76
- CORT $67.23
- Revenue Growth
- HSIC 2.29
- CORT 25.71
- 52 Week Low
- HSIC $60.56
- CORT $38.68
- 52 Week High
- HSIC $82.49
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- HSIC 43.53
- CORT 61.26
- Support Level
- HSIC $66.98
- CORT $69.03
- Resistance Level
- HSIC $70.69
- CORT $75.54
- Average True Range (ATR)
- HSIC 1.66
- CORT 2.62
- MACD
- HSIC -0.06
- CORT 0.45
- Stochastic Oscillator
- HSIC 10.66
- CORT 98.91
About HSIC Henry Schein Inc.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.